SKI Market

Indian Indices

Sensex

77,678.14 -1,240.76
( -1.57%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

52,808.52 -2,812.32
(-5.06%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

58.83

6501.14

EPS(TTM)

Face Value()

Div & Yield %

5.65

0.15

Back

emco ltd

Sammaan Capital reports consolidated net profit of Rs 308.47 crore in the September 2025 quarter

Oct 31,2025

Net profit of Sammaan Capital reported to Rs 308.47 crore in the quarter ended September 2025 as against net loss of Rs 2760.72 crore during the previous quarter ended September 2024. Sales declined 7.10% to Rs 2250.60 crore in the quarter ended September 2025 as against Rs 2422.49 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2250.60	2422.49	-7
OPM %	76.53	-100.28	-
PBDT	446.27	-3665.17	LP
PBT	425.03	-3684.95	LP
NP	308.47	-2760.72	LP

77,678.14 -1,240.76 ( -1.57%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

52,808.52 -2,812.32 (-5.06%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)